Investigation of risk factors for the onset of glucose intolerance and thyroid disease in patients with the immune checkpoint inhibitors
Not Applicable
- Conditions
- melanoma, lung cancer
- Registration Number
- JPRN-UMIN000026702
- Lead Sponsor
- Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Not provided
Exclusion Criteria
The patients whose ADL weakened remarkably.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The onset of glucose intolerance and thyroid function after the immune checkpoint inhibitors
- Secondary Outcome Measures
Name Time Method